Nomad Power Solutions Inc (NMAD)

NASD · Industrials · Electrical Equipment & Parts · USA

Nomad Power Solutions Inc is a micro cap company (market value under $300 million) in the Electrical Equipment & Parts industry.

Nomad Power Solutions Inc is a clinical-stage biopharmaceutical company developing cancer therapies based on protein phosphatase 2A inhibitors, with LB-100 in clinical trials for ovarian, colon, and soft tissue cancers. The company holds a controlling stake in Liora Technologies Europe Ltd., which creates electronically controlled proton therapy systems for treating various cancer types.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Nomad Power Solutions Inc stock.

Our verdict on NMAD

Not valued: We cannot value this company yet.

ETFs with the most weight in NMAD

Browse

Peers in Electrical Equipment & Parts

All 55 Electrical Equipment & Parts stocks

Cheaper than NMAD in Electrical Equipment & Parts

18 more in this industry show a wider margin of safety.

Is NMAD undervalued or overvalued?

We do not publish a verdict on NMAD yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of NMAD?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.